Maihofer, Adam X. http://orcid.org/0000-0003-4517-1623
Ratanatharathorn, Andrew
Hemmings, Sian M. J. http://orcid.org/0000-0001-8461-1017
Costenbader, Karen H.
Michopoulos, Vasiliki http://orcid.org/0000-0003-2531-923X
Polimanti, Renato http://orcid.org/0000-0003-0745-6046
Rothbaum, Alex O.
Seedat, Soraya http://orcid.org/0000-0002-5118-786X
Mikita, Elizabeth A. http://orcid.org/0000-0002-2113-8274
Smith, Alicia K. http://orcid.org/0000-0002-8537-5156
Salem, Rany M.
Shaffer, Richard A.
Wu, Tianying
Sebat, Jonathan
Ressler, Kerry J. http://orcid.org/0000-0002-5158-1103
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Koenen, Karestan C. http://orcid.org/0000-0003-2978-7655
Wolf, Erika J. http://orcid.org/0000-0003-2666-2435
Sumner, Jennifer A. http://orcid.org/0000-0002-0217-7171
Nievergelt, Caroline M. http://orcid.org/0000-0001-5766-8923
,
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH106595, R01MH106595, R01MH106595, R01MH106595)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 30 June 2023
Revised: 21 February 2024
Accepted: 11 March 2024
First Online: 1 April 2024
Competing interests
: MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech and has stock options in Oxeia Biopharmaceuticals and Epivario. RP received a research grant and is paid for his editorial work on the journal Complex Psychiatry. All other authors report no biomedical financial interests or potential conflicts of interest.